Nina Lathia, Nicole Mittmann, Carlo DeAngelis, Sandra Knowles, Matthew Cheung, Eugenia Piliotis, Neil Shear and Scott Walker Evaluation of direct medical costs of hospitalization for febrile neutropenia Cancer 116
Article first published online: 22 DEC 2009 | DOI: 10.1002/cncr.24773
Treatment of febrile neutropenia is expensive, because it typically involves in-hospital care. Direct medical costs of hospitalization for febrile neutropenia were quantified in this study, and findings could be used in future economic evaluations of strategies to prevent and treat this condition.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field